NO912099L - Ekspresjon av hiv-proteiner i drosophilia-celler. - Google Patents

Ekspresjon av hiv-proteiner i drosophilia-celler.

Info

Publication number
NO912099L
NO912099L NO91912099A NO912099A NO912099L NO 912099 L NO912099 L NO 912099L NO 91912099 A NO91912099 A NO 91912099A NO 912099 A NO912099 A NO 912099A NO 912099 L NO912099 L NO 912099L
Authority
NO
Norway
Prior art keywords
drosophilia
expression
cells
hiv proteins
hiv
Prior art date
Application number
NO91912099A
Other languages
English (en)
Other versions
NO912099D0 (no
NO314090B1 (no
Inventor
Hanne Ranch Johansen
Martin Rosenberg
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO912099D0 publication Critical patent/NO912099D0/no
Publication of NO912099L publication Critical patent/NO912099L/no
Publication of NO314090B1 publication Critical patent/NO314090B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19912099A 1988-12-01 1991-05-31 HIV-proteingenekspresjonsenhet, DNA-vektor som omfatter den, Drosophila-celle transfektert med vektoren, HIV gp 120 og HIV gp 160-proteinprodusert i en kultur av nevnte celler, vaksine og diagnostisk agens som omfatterproteinet, samtfremgangs NO314090B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27838688A 1988-12-01 1988-12-01
PCT/US1989/005155 WO1990006358A1 (en) 1988-12-01 1989-11-29 Expression of hiv proteins in drosophila cells

Publications (3)

Publication Number Publication Date
NO912099D0 NO912099D0 (no) 1991-05-31
NO912099L true NO912099L (no) 1991-07-31
NO314090B1 NO314090B1 (no) 2003-01-27

Family

ID=23064787

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19912099A NO314090B1 (no) 1988-12-01 1991-05-31 HIV-proteingenekspresjonsenhet, DNA-vektor som omfatter den, Drosophila-celle transfektert med vektoren, HIV gp 120 og HIV gp 160-proteinprodusert i en kultur av nevnte celler, vaksine og diagnostisk agens som omfatterproteinet, samtfremgangs

Country Status (12)

Country Link
EP (1) EP0446272A4 (no)
JP (1) JP3085704B2 (no)
KR (1) KR0152525B1 (no)
AU (1) AU630649B2 (no)
CA (1) CA2003794C (no)
DK (1) DK175461B1 (no)
FI (1) FI113475B (no)
IL (1) IL92470A (no)
NO (1) NO314090B1 (no)
PT (1) PT92477A (no)
WO (1) WO1990006358A1 (no)
ZA (1) ZA899150B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012279018B2 (en) * 2011-07-05 2017-06-08 Children's Medical Center Corporation N-terminal deleted GP120 immunogens
WO2013052095A2 (en) 2011-10-03 2013-04-11 Duke University Vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272858A3 (en) * 1986-12-15 1989-07-12 Repligen Corporation Recombinant hiv envelope proteins produced in insect cells
CA1341345C (en) * 1987-05-08 2002-03-05 Hanne Ranch Johansen Expression of foreign genes in drosophila cells
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
KR910700352A (ko) * 1988-12-21 1991-03-14 스미스클라인 바이올로지칼즈(s.a.) 곤충 세포내에서 플라스모듐 서컴스포로 조이트 단백질의 발현

Also Published As

Publication number Publication date
KR0152525B1 (ko) 1998-10-01
DK175461B1 (da) 2004-11-01
EP0446272A4 (en) 1993-01-07
NO912099D0 (no) 1991-05-31
IL92470A (en) 1997-01-10
ZA899150B (en) 1991-04-24
AU630649B2 (en) 1992-11-05
JP3085704B2 (ja) 2000-09-11
IL92470A0 (en) 1990-08-31
AU4755290A (en) 1990-06-26
NO314090B1 (no) 2003-01-27
PT92477A (pt) 1990-06-29
JPH04501954A (ja) 1992-04-09
KR910700344A (ko) 1991-03-14
WO1990006358A1 (en) 1990-06-14
FI113475B (fi) 2004-04-30
DK104991D0 (da) 1991-05-31
DK104991A (da) 1991-05-31
CA2003794C (en) 2000-02-08
FI912635A0 (fi) 1991-05-31
CA2003794A1 (en) 1990-06-01
EP0446272A1 (en) 1991-09-18

Similar Documents

Publication Publication Date Title
DE68919449D1 (de) Herstellung von IBDV in kontinuierlichen Zellinien.
DE68920223D1 (de) Enzymelektroden und ihre Herstellung.
DE3687915D1 (de) Aenderung von gesichtsausdruecken in der kinematographie.
ATE114168T1 (de) Anti-sense-regulierung von genexpression in pflanzenzellen.
DE3787356D1 (de) Expression von höheren eukaryotischen genen in aspergillus.
DE68924285D1 (de) Erzeugung von richtungsbestimmten Löchern in Silizium.
NO890774D0 (no) Ekspresjon av hiv-bindende proteiner.
DE68914571D1 (de) Elektroeinsetzung von Proteinen in Membranen von Tierzellen.
DE68920414D1 (de) Herstellungsverfahren von Sonnenzellen.
NO891718L (no) Ekspresjon av humant interleukin-2 i metylotrofe gjaersorter.
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
DE3676604D1 (de) Expression von epa in saeugetierzellen.
FI880636A0 (fi) Foerfarande foer inaktivering av med hoelje foersedda virus i en medelst en cell in vitro framstaellda proteinprodukter.
NO912099L (no) Ekspresjon av hiv-proteiner i drosophilia-celler.
DE3872886D1 (de) Uebertragung von geschwindigkeits- und drehzahlmesswerten.
NO891687D0 (no) Ekspresjon av hepatitt-b pres2-protein i metylotrofe gjaersorter.
DK643188A (da) Ekspression af hiv-proteiner i e.coli og s.cerevisiae
DE68913304D1 (de) Transesterifikation von alkoxyestern.
NO891715D0 (no) Ekspresjon av interferon-8 i metylotrofe gjaersorter.
DE68905638D1 (de) Herstellung von alkansulfonylhaliden und alkansulfonsaeuren.
FI870848A0 (fi) Anordning foer dragning av kablar in i skyddsroer foer kablar.
ATE59407T1 (de) Expression von epa in saeugetierzellen.
NO891717D0 (no) Ekspresjon av hiv 24 kda gag-protein i metylotrofe gjaersorter.
ATE98679T1 (de) Herstellung des hblv-virus in der hsb-2 zelllinie.
FI851796A0 (fi) Kamflaenskonstruktion foer fastsaettning av tvao in i varandra placerbara roerformiga stycken.

Legal Events

Date Code Title Description
MK1K Patent expired